Search Results - "Neelapu, S.S."

Direct comparison of in vivo fate of second and third-generation CD19-specific chimeric antigen receptor (CAR)-T cells in patients with b cell non-hodgkin lymphoma (B-NHL): Reversal of toxicity from tonic signaling by Gomes da Silva, D, Mukherjee, M, Madhuwanti, S, Dakhova, O, Liu, H, Grilley, B, Gee, A, Neelapu, S.S, Rooney, C, Heslop, H, Savoldo, B, Dotti, G, Brenner, M, Mamonkin, M, Ramos, C.A

Get full text

Induction of TLR4-dependent CD8+ T cell immunity by murine β-defensin2 fusion protein vaccines by Park, H.J, Qin, H, Cha, S.C, Sharma, R, Chung, Y, Schluns, K.S, Neelapu, S.S, Overwijk, W.W, Hwu, P, Kwak, L.W

“…Abstract Our laboratory previously described the strategy of fusing chemokine receptor ligands to antigens in order to generate immunogenic DNA vaccines. In…”
Get full text

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma by Neelapu, Sattva S, Locke, Frederick L, Bartlett, Nancy L, Lekakis, Lazaros J, Miklos, David B, Jacobson, Caron A, Braunschweig, Ira, Oluwole, Olalekan O, Siddiqi, Tanya, Lin, Yi, Timmerman, John M, Stiff, Patrick J, Friedberg, Jonathan W, Flinn, Ian W, Goy, Andre, Hill, Brian T, Smith, Mitchell R, Deol, Abhinav, Farooq, Umar, McSweeney, Peter, Munoz, Javier, Avivi, Irit, Castro, Januario E, Westin, Jason R, Chavez, Julio C, Ghobadi, Armin, Komanduri, Krishna V, Levy, Ronald, Jacobsen, Eric D, Witzig, Thomas E, Reagan, Patrick, Bot, Adrian, Rossi, John, Navale, Lynn, Jiang, Yizhou, Aycock, Jeff, Elias, Meg, Chang, David, Wiezorek, Jeff, Go, William Y

“…In 101 patients with refractory large B-cell lymphoma, anti-CD19 chimeric antigen receptor (CAR) T-cell therapy (axicabtagene ciloleucel) resulted in an…”
Get full text

CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL THERAPY FOR ASPERGILLOSIS by Kumar, P., Wurster, S., daSilva, T., Hauser, P., Neelapu, S.S., Kontoyiannis, D.

“…Invasive aspergillosis (IA) is a common and deadly mold infection in immunocompromised patients. As morbidity and mortality of IA are primarily driven by poor…”
Get full text

Bridging Radiotherapy prior to Brexucabtagene Autoleucel for Relapsed/Refractory Mantle Cell Lymphoma by Fetooh, A., Lionel, A., Fang, P., Nze, C.C., Ahmed, S., Westin, J., Flowers, C., Pinnix, C.C., Dabaja, B., Gunther, J.R., Neelapu, S.S., Wang, M.L., Jain, P., Wu, S.Y.

“…Brexucabtagene autoleucel (BA) is a CD19-directed chimeric antigen receptor T-cell (CAR-T) therapy approved in the treatment of relapsed/refractory (r/r)…”
Get full text

Outcomes and Toxicities in Patients with Diffuse Large B-Cell Lymphoma of the Gastrointestinal Tract by Cha, E., Manzar, G.S., Corrigan, K.L., Yoder, A.K., Schrank, B.R., Nasr, L.F., Gunther, J.R., Strati, P., Ahmed, S., Fayad, L., Nair, R., Steiner, R., Westin, J., Nastoupil, L., Neelapu, S.S., Pinnix, C.C., Dabaja, B., Wu, S.Y., Fang, P.

“…Diffuse large B-cell lymphoma (DLBCL) involving the gastrointestinal (GI) tract is rare and long-term outcomes are not well defined. Combined modality therapy…”
Get full text

Characterization of Lymphopenia during Bridging Radiation Therapy Prior to CAR-T Cell Therapy in Patients with Aggressive B Cell Lymphomas by Manzar, G.S., Wu, S.Y., Dudzinski, S.O., Rooney, M.K., Jallouk, A., Yoder, A.K., Nasr, L.F., Gunther, J.R., Sallard, G., Ahmed, S., Fayad, L., Nair, R., Steiner, R., Westin, J., Nastoupil, L., Neelapu, S.S., Dabaja, B., Pinnix, C.C., Strati, P., Fang, P.

“…Bridging RT (bRT) may be used as a strategy for disease control in patients with relapsed/refractory aggressive B cell lymphoma treated with anti-CD19-directed…”
Get full text

Ultra Low-Dose Radiation for Extranodal Marginal Zone Lymphoma of the Lung by Wu, S.Y., Gunther, J.R., Manzar, G.S., Corrigan, K.L., Damron, E.P., Schrank, B.R., Nasr, L.F., Chihara, D., Malpica Castillo, L.E., Nair, R., Steiner, R., Jain, P., Neelapu, S.S., Samaniego, F., Rodriguez, M.A., Strati, P., Nastoupil, L., Dabaja, B., Pinnix, C.C., Fang, P.

“…Definitive radiation treatment (RT) for extranodal marginal zone lymphoma (ENMZL) of mucosal associated lymphoid tissue historically involves treatment to…”
Get full text

Outcomes with Bridging Radiation Therapy Prior to CAR-T Cell Therapy in Pts with Aggressive B Cell Lymphomas by Manzar, G.S., Wu, S.Y., Dudzinski, S.O., Jallouk, A., Yoder, A.K., Nasr, L.F., Corrigan, K.L., Gunther, J.R., Ahmed, S., Fayad, L., Nair, R., Steiner, R., Westin, J., Neelapu, S.S., Dabaja, B., Strati, P., Nastoupil, L., Pinnix, C.C., Fang, P., Rooney, M.K.

“…Select patient (pts) with relapsed/refractory aggressive B cell lymphoma may benefit from bridging radiation (bRT) prior to anti-CD19-directed chimeric antigen…”
Get full text

Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: a phase II clinical trial by Wang, M, Fowler, N, Wagner-Bartak, N, Feng, L, Romaguera, J, Neelapu, S S, Hagemeister, F, Fanale, M, Oki, Y, Pro, B, Shah, J, Thomas, S, Younes, A, Hosing, C, Zhang, L, Newberry, K J, Desai, M, Cheng, N, Badillo, M, Bejarano, M, Chen, Y, Young, K H, Champlin, R, Kwak, L, Fayad, L

“…Lenalidomide–rituximab therapy is effective in grade 1–2 follicular and mantle cell lymphoma, but its efficacy in diffuse large B-cell lymphoma (DLBCL),…”
Get full text

Response Adapted Ultra Low Dose Radiation Therapy for the Definitive Management of Orbital Indolent B-Cell Lymphoma by Pinnix, C.C., Dabaja, B., Gunther, J.R., Fang, P., Wu, S.Y., Nastoupil, L., Strati, P., Nair, R., Ahmed, S., Steiner, R., Westin, J., Neelapu, S.S., Rodriguez, M.A., Lee, H., Wang, M.L., Fowler, N., Flowers, C., Feng, L., Chi, L., Esmaeli, B.

Get full text

A Prospective Trial of Radiation Therapy Efficacy and Toxicity for Localized Mucosa-associated Lymphoid Tissue (MALT) Lymphoma by Fang, P., Gunther, J.R., Pinnix, C.C., Dong, W., Strati, P., Nastoupil, L., Fowler, N., Steiner, R., Nair, R., Ahmed, S., Westin, J., Neelapu, S.S., Ha, C.S., Dabaja, B.

Get full text

ABCG2 is a direct transcriptional target of hedgehog signaling and involved in stroma-induced drug tolerance in diffuse large B-cell lymphoma by Singh, R R, Kunkalla, K, Qu, C, Schlette, E, Neelapu, S S, Samaniego, F, Vega, F

“…Successful treatment of diffuse large B-cell lymphoma (DLBCL) is frequently hindered by the development of resistance to conventional chemotherapy resulting in…”
Get full text

Partial Omission of Bleomycin for Early Stage Hodgkin Lymphoma Patients Treated with Combined Modality Therapy: Does Incomplete ABVD Lead to Inferior Outcomes? by Gunther, J.R., Pinnix, C.C., Glober, G., Christopherson, K.M., Lee, H., Ahmed, S., Steiner, R.E., Nair, R., Strati, P., Neelapu, S.S., Nastoupil, L., Dabaja, B.

Get full text

Assessing the Role of Radiation Therapy for Primary Mediastinal Large B-Cell Lymphoma in the Setting of PET Avid Disease after Chemotherapy by Gjyshi, O., Boyce-Fappiano, D., Gunther, J.R., Fang, P., Nastoupil, L., Nair, R., Steiner, R., Strati, P., Ahmed, S., Khoury, J., Westin, J., Rodriguez, M.A., Fayad, L., Neelapu, S.S., Flowers, C., Dabaja, B., Pinnix, C.C.

Get full text

Radiation Therapy for Refractory High-grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements by Liu, Y., Augustyn, A., Gunther, J.R., Fang, P., Nastoupil, L., Ahmed, S., Strati, P., Nair, R., Steiner, R., Westin, J., Rodriguez, M.A., Neelapu, S.S., Flowers, C., Khoury, J., Medeiros, L.J., Dabaja, B., Pinnix, C.C.

Get full text

Prognostic Value of Disease Location in Secondary Central Nervous System Diffuse Large B-Cell Lymphoma by Al Feghali, K.A., Fang, P., Gule-Monroe, M.K., Khoury, J., Gunther, J.R., Milgrom, S.A., Sheu, T., Nair, R., Ahmed, S., Steiner, R., Strati, P., Nastoupil, L., Neelapu, S.S., Pinnix, C.C., Fowler, N., Flowers, C., Dabaja, B.

Get full text

Concurrent Radiation Therapy With the Antibody-Drug Conjugates Brentuximab Vedotin and Polatuzumab Vedotin by Wu, S.Y., Fang, P., Huen, A.O., Iyer, S.P., Nair, R., Steiner, R., Castillo, L.E.Malpica, Duvic, M., Ahmed, S., Jain, P., Fayad, L., Strati, P., Westin, J., Neelapu, S.S., Nastoupil, L., Pinnix, C.C., Dabaja, B., Gunther, J.R.

“…Brentuximab vedotin (BV) and polatuzumab vedotin (PV) are antibody-drug conjugates targeting CD30 and CD79B, respectively, approved for the treatment of select…”
Get full text

Primary Gastric Diffuse Large B-Cell Lymphoma Treated with Abbreviated Chemoimmunotherapy and Contemporary Radiation Therapy has Excellent Outcomes with Minimal Toxicity by Christopherson, K.M., Gunther, J.R., Milgrom, S.A., Wong, P.F., Ning, M.S., Nastoupil, L., Neelapu, S.S., Fowler, N., Fanale, M.A., Westin, J., Oki, Y., Khoury, J., Dabaja, B., Pinnix, C.C.

Get full text

Acute leucoencephalomyelopathy and quadriparesis after CAR T-cell therapy by Nair, Ranjit, Drillet, Gaëlle, Lhomme, Faustine, Le Bras, Anthony, Michel, Laure, Rossi, John, Sherman, Marika, Xue, Allen, Kerber, Anne, Jittapiromsak, Nutchawan, Chi, Linda, Tummala, Sudhakar, Neelapu, Sattva S, Houot, Roch

Get full text